Shot in arm for Covid fight as jab for 5- to 11-year-olds gets green light
US regulators say risk of myocarditis is very low, but a decision on a jab for 12- to 17-year-olds has been delayed
Pfizer’s Covid-19 shot for children age five to 11 was backed unanimously by advisers to the US Centers for Disease Control and Prevention (CDC) in a vote that will help usher in a new phase in the pandemic response.
The CDC’s advisory committee on immunisation practices (ACIP) voted 14-0 in favour of giving young children the shot developed by Pfizer and BioNTech after it was cleared on Friday by US regulators.
“Today is a monumental day in the course of this pandemic and one that many of us have been very eager to see,” CDC director Rochelle Walensky said. “For almost two full years schools have been fundamentally changed; there have been children in second grade who have never experienced a normal school year.”..